Glycemic profile variability as an independent predictor of diabetic retinopathy in patients with type 2 diabetes: a prospective cohort study

被引:0
|
作者
Firouzabadi, Fatemeh Dehghani [1 ,2 ]
Poopak, Amirhossein [1 ]
Samimi, Sahar [1 ]
Deravi, Niloofar [1 ]
Nakhaei, Pooria [1 ]
Sheikhy, Ali [1 ,2 ]
Moosaie, Fatemeh [1 ]
Rabizadeh, Soghra [1 ]
Meysamie, Alipasha [1 ]
Nakhjavani, Manouchehr [1 ]
Esteghamati, Alireza [1 ]
机构
[1] Univ Tehran Med Sci, Vali Asr Hosp, Endocrinol & Metab Res Ctr EMRC, Tehran, Iran
[2] NIH, Dept Radiol & Imaging Sci, Clin Ctr, Bethesda, MD 20892 USA
来源
FRONTIERS IN ENDOCRINOLOGY | 2024年 / 15卷
关键词
glycemic profile variability; HbA1c; 2hPP; FBS; diabetes type 2; diabetic retinopathy; MICROVASCULAR COMPLICATIONS; OXIDATIVE STRESS; RISK; GLUCOSE; DYSFUNCTION;
D O I
10.3389/fendo.2024.1383345
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Glycemic variability is a novel predictor for diabetic complications. Different studies have demonstrated contradictory results for the association between HbA1c variability and diabetic retinopathy. We aimed to assess the relationship between visit-to-visit variability in glycemic profile (HbA1c, 2hPP, and FBS) and diabetic retinopathy.Methods Patients with type 2 diabetes were monitored for the development of retinopathy for 10 years. The association between the incidence of retinopathy and glycemic variability was assessed via Cox regression analysis, and coefficient of variation for glycemic indices was compared using independent sample t-test.Results Patients with diabetic retinopathy had significantly higher glycemic profile variability. The incidence of retinopathy was positively correlated with cv-FBS10% (10% of coefficient of variance), cv-FBS20%, cv-2hpp10%, and cv-HbA1c5%. Our analysis revealed that the higher variability of FBS increased the incidence and progression of retinopathy (HR: 12.29, p-value = 0.003).Conclusion Our findings demonstrated glycemic profile variability as an independent risk factor for diabetic retinopathy in patients with type 2 diabetes and support glycemic profile variability measurement in addition to common glycemic parameters to improve risk stratification in patients with type 2 diabetes. Further investigation is required to demonstrate the long-term effects of alleviating glycemic variability on the prognosis of patients with type 2 diabetes.
引用
收藏
页数:8
相关论文
共 50 条
  • [11] Association of glycemic control with progression of diabetic retinopathy in type 2 diabetes mellitus patients in Malaysia
    Huri, Hasniza Zaman
    Huey, Chua Chew
    Mustafa, Norasyikin
    Mohamad, Nor Fadhilah
    Kamalden, Tengku Ain
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 54 (02)
  • [12] Proliferative diabetic retinopathy is a predictor of coronary artery disease in Japanese patients with type 2 diabetes
    Yamada, Tomohide
    Itoi, Takanobu
    Kiuchi, Yuka
    Nemoto, Mitsuru
    Yamashita, Shigeo
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 96 (01) : E4 - E6
  • [13] Diabetic retinopathy predicts cardiovascular disease independently of subclinical atherosclerosis in individuals with type 2 diabetes: A prospective cohort study
    Castelblanco, Esmeralda
    Granado-Casas, Minerva
    Hernandez, Marta
    Pinyol, Montserrat
    Correig, Eudald
    Julve, Josep
    Idalia Rojo-Lopez, Marina
    Alonso, Nuria
    Avogaro, Angelo
    Ortega, Emilio
    Mauricio, Didac
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [14] Diabetic Retinopathy as a Predictor of Angiographic Coronary Atherosclerosis Severity in Patients with Type 2 Diabetes Mellitus
    Eid, Mohamed
    Mounir, Amr
    El Etriby, Shehab
    Al Taher, Ali
    Ezzat, Mohamed A. W.
    DIABETES METABOLIC SYNDROME AND OBESITY, 2022, 15 : 1485 - 1494
  • [15] Lipoprotein (a) as a predictor of diabetic retinopathy in patients with type 2 diabetes: A systematic review
    Gholami Chahkand, Mohammad Sadra
    Esmaeilpour Moallem, Fatemeh
    Qezelgachi, Abolfazl
    Seifouri, Kiana
    Pesaran Afsharian, Armin
    Sheikhzadeh, Farzad
    Poursalehi, Atefe
    Fani Sadrabadi, Fateme Sadat
    Saghab Torbati, Mehrnush
    Ramezanzade, Mohaddese
    Alishiri, Goharsharieh
    Ansari, Arina
    Zare Dehabadi, Emad
    Karimi Matloub, Saeed
    Sheikh, Zahra
    Deravi, Niloofar
    Mehrtabar, Saba
    Chichagi, Fatemeh
    Faal Hamedanchi, Neda
    Arzaghi, Mohammadreza
    Asadi, Mahla
    Alsadat Dadkhah, Parisa
    Ansari, Akram
    DIABETES & VASCULAR DISEASE RESEARCH, 2023, 20 (06)
  • [16] HbA1c variability and long-term glycemic control are linked to diabetic retinopathy and glomerular filtration rate in patients with type 1 diabetes and multiethnic background
    Garcia Franco da Rosa, Larissa Carolina
    Zajdenverg, Lenita
    Souto, Debora Lopes
    Dantas, Joana Rodrigues
    Rocha Pinto, Marcus Vinicius
    da Costa Mendes de Salles, Gil Fernando
    Rodacki, Melanie
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2019, 33 (09) : 610 - 615
  • [17] Microvascular endothelial function is an independent predictor for albuminuria progression among Asians with type 2 diabetes-A prospective cohort study
    Zhang, Xiao
    Low, Serena
    Ang, Keven
    Yeoh, Lee Ying
    Tavintharan, Subramaniam
    Sum, Chee Fang
    Lim, Su Chi
    MICROCIRCULATION, 2018, 25 (04)
  • [18] Metabolic control and diabetic retinopathy in patients with diabetes type 2
    Kosanovic-Jakovic, N.
    Resan, M.
    Dimitrijevic-Sreckovic, V.
    Vukosavljevic, M.
    Milenkovic, S.
    Colak, E.
    Risovic, D.
    Avramovic, S.
    Canovic, F.
    SPEKTRUM DER AUGENHEILKUNDE, 2010, 24 (03) : 157 - 161
  • [19] GLYCEMIC VARIABILITY IN TYPE 2 DIABETIC PATIENTS WITH CHRONIC KIDNEY DISEASE
    Steriade, Oana
    Pantea-Stoian, Anca
    Savu, Octavian
    Florentiu, Ariel
    Cioca, Gabriela
    Purcarea, Victor Lorin
    Elian, Viviana
    INTERDIAB 2016: DIABETES MELLITUS AS CARDIOVASCULAR DISEASE, 2016, : 453 - 457
  • [20] Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes
    Orsi, Emanuela
    Solini, Anna
    Bonora, Enzo
    Vitale, Martina
    Garofolo, Monia
    Fondelli, Cecilia
    Trevisan, Roberto
    Vedovato, Monica
    Cavalot, Franco
    Zerbini, Gianpaolo
    Nicolucci, Antonio
    Pugliese, Giuseppe
    DIABETES & METABOLISM, 2023, 49 (02)